Nada Lukkahatai1, Brian Walitt2, Alexandra Espina3, Alves Gelio4, Leorey N Saligan3. 1. School of Nursing, University of Nevada, Las Vegas, and National Institute of Nursing Research, NIH, Bethesda, Maryland. 2. National Institute of Nursing Research, NIH, Bethesda, Maryland, and Medstar Research Institute, Washington Hospital Center, Washington, DC. 3. National Institute of Nursing Research, NIH, Bethesda, Maryland. 4. National Center for Biotechnology Information, National Library of Medicine, Bethesda, Maryland.
Abstract
OBJECTIVE: To develop a symptoms cluster model that can describe factors of fibromyalgia syndrome (FMS) associated with fatigue severity as reported by the sample and to explore FMS clinical symptom subclusters based on varying symptom intensities. METHODS: FMS individuals (n = 120, 82% ages 31-60 years, 90% women, 59% white) diagnosed with the 1990 or 2010 American College of Rheumatology diagnostic criteria were enrolled. Participants completed multiple validated self-report questionnaires to measure fatigue, pain, depression, anxiety, pain catastrophizing, daytime sleepiness, cognitive function, and FMS-related polysymptomatic distress. Cluster analysis using SPSS 19.0 and structural equation modeling using AMOS 17.0 were used. RESULTS: Final structural equation modeling the symptoms cluster model showed good fit and revealed that FMS fatigue was associated with widespread pain, symptoms severity, pain intensity, pain interference, cognitive dysfunction, catastrophizing, anxiety, and depression (χ(2) = 121.72 (98df), P > 0.05, χ(2) /df = 1.242, comparative fit index = 0.982, root mean square error of approximation = 0.045). Two distinct clinical symptom subclusters emerged: subcluster 1 (78% of total subjects), defined by widespread pain, unrefreshed waking, and somatic symptoms, and subcluster 2 (22% of total subjects), defined by fatigue and cognitive dysfunction with pain being a less severe and less widespread occurrence. CONCLUSION: Overall, subcluster 1 had more intense symptoms than subcluster 2. FMS symptoms may be categorized into 2 clinical subclusters. These findings have implications for an illness whose diagnosis and management are symptom dependent. A longitudinal study capturing the variability in the symptom experience of FMS subjects is warranted.
OBJECTIVE: To develop a symptoms cluster model that can describe factors of fibromyalgia syndrome (FMS) associated with fatigue severity as reported by the sample and to explore FMS clinical symptom subclusters based on varying symptom intensities. METHODS: FMS individuals (n = 120, 82% ages 31-60 years, 90% women, 59% white) diagnosed with the 1990 or 2010 American College of Rheumatology diagnostic criteria were enrolled. Participants completed multiple validated self-report questionnaires to measure fatigue, pain, depression, anxiety, pain catastrophizing, daytime sleepiness, cognitive function, and FMS-related polysymptomatic distress. Cluster analysis using SPSS 19.0 and structural equation modeling using AMOS 17.0 were used. RESULTS: Final structural equation modeling the symptoms cluster model showed good fit and revealed that FMS fatigue was associated with widespread pain, symptoms severity, pain intensity, pain interference, cognitive dysfunction, catastrophizing, anxiety, and depression (χ(2) = 121.72 (98df), P > 0.05, χ(2) /df = 1.242, comparative fit index = 0.982, root mean square error of approximation = 0.045). Two distinct clinical symptom subclusters emerged: subcluster 1 (78% of total subjects), defined by widespread pain, unrefreshed waking, and somatic symptoms, and subcluster 2 (22% of total subjects), defined by fatigue and cognitive dysfunction with pain being a less severe and less widespread occurrence. CONCLUSION: Overall, subcluster 1 had more intense symptoms than subcluster 2. FMS symptoms may be categorized into 2 clinical subclusters. These findings have implications for an illness whose diagnosis and management are symptom dependent. A longitudinal study capturing the variability in the symptom experience of FMS subjects is warranted.
Authors: Adam P Spira; Sherry A Beaudreau; Katie L Stone; Eric J Kezirian; Li-Yung Lui; Susan Redline; Sonia Ancoli-Israel; Kristine Ensrud; Anita Stewart Journal: J Gerontol A Biol Sci Med Sci Date: 2011-09-20 Impact factor: 6.053
Authors: Frederick Wolfe; Daniel J Clauw; Mary-Ann Fitzcharles; Don L Goldenberg; Winfried Häuser; Robert S Katz; Philip Mease; Anthony S Russell; I Jon Russell; John B Winfield Journal: J Rheumatol Date: 2011-02-01 Impact factor: 4.666
Authors: L A Jason; K M Jordan; J A Richman; A W Rademaker; C F Huang; W McCready; J Shlaes; C P King; D Landis; S Torres; T Haney-Davis; E L Frankenberry Journal: J Health Psychol Date: 1999-01
Authors: Thorsten Giesecke; David A Williams; Richard E Harris; Thomas R Cupps; Xiaoming Tian; Thomas X Tian; Richard H Gracely; Daniel J Clauw Journal: Arthritis Rheum Date: 2003-10
Authors: Ann Vincent; Brian D Lahr; Frederick Wolfe; Daniel J Clauw; Mary O Whipple; Terry H Oh; Debra L Barton; Jennifer St Sauver Journal: Arthritis Care Res (Hoboken) Date: 2013-05 Impact factor: 4.794
Authors: Linda F Brown; Kevin L Rand; Silvia M Bigatti; Jesse C Stewart; Dale E Theobald; Jingwei Wu; Kurt Kroenke Journal: Health Psychol Date: 2012-08-27 Impact factor: 4.267
Authors: Javier García-Campayo; Antoni Serrano-Blanco; Baltasar Rodero; Rosa Magallón; Marta Alda; Eva Andrés; Juan V Luciano; Yolanda López del Hoyo Journal: Trials Date: 2009-04-23 Impact factor: 2.279
Authors: Ariel B Neikrug; Gary Donaldson; Eli Iacob; Sam L Williams; Christopher A Hamilton; Akiko Okifuji Journal: Pain Date: 2017-08 Impact factor: 6.961
Authors: Katherine Hadlandsmyth; Dana L Dailey; Barbara A Rakel; M Bridget Zimmerman; Carol Gt Vance; Ericka N Merriwether; Ruth L Chimenti; Katharine M Geasland; Leslie J Crofford; Kathleen A Sluka Journal: J Health Psychol Date: 2017-10-27
Authors: Nada Lukkahatai; Brian Walitt; Enrique J Deandrés-Galiana; Juan Luis Fernández-Martínez; Leorey N Saligan Journal: J Pain Res Date: 2018-11-21 Impact factor: 3.133
Authors: Alexandra Braun; Dimitar Evdokimov; Johanna Frank; Paul Pauli; Nurcan Üçeyler; Claudia Sommer Journal: PLoS One Date: 2020-12-28 Impact factor: 3.240
Authors: Lucía Sanromán; Patricia Catalá; Carmen Écija; Carlos Suso-Ribera; Jesús San Román; Cecilia Peñacoba Journal: Int J Environ Res Public Health Date: 2022-04-01 Impact factor: 3.390